Innovative Products

Product Platforms

We at Avanti Therapeutics’ believe that our product portfolio and research pipeline are the lifeblood of our success. Based on Aayush-our technology platform, Avanti is developing products with multiple – rather than single – treatment opportunities. Importantly, Avanti along with its preferred partners is working on a large number of products that target diseases with large patient populations.
Using the proprietary platform, Avanti is developing products for big treatment areas – such as cancer, and cardiovascular diseases and central nervous system disorders – where potential return in investment is greatest. Rather than developing "me-too" treatments for disease areas that already well served by existing technologies in the market, Avanti is developing novel innovative products that significantly enhance the efficacy and safety profile of the current market leading products.
We have completed the POC studies for representative products in each of the product portfolio domain, including:

• Oncology
• Cardiovascular
• CNS
• Regenerative Medicine
• Vaccines

Considering the capabilities of our technology and nature of our product pipelines, the management strongly believes that the products can follow a fast track clinical development with greater chances of regulatory approval, market launch and commercial success.